This is the third post in a series on the TransCelerate Shared Investigator Platform (SIP). For more background on TransCelerate and SIP, see the previous two posts. In today’s post, we’ll be exploring the benefits of adopting the SIP.
First and foremost, the SIP resolves one of the biggest complaints expressed by sites, which is having to keep track of usernames and passwords for all of the IT systems across multiple studies and sponsors. It also solves the problem of having to remember which URL goes with which login credentials. Additionally, it allows investigators to enter information about themselves and their facility just once, and have that information shared across studies and sponsors.
Learn how AI/ML can be used by pharmaceutical and medical device companies to improve the clinical data review and cleansing process.
Beyond those administrative tasks, the SIP offers a consolidated and standardized user experience that employs standard messaging functionality, training tracking, and document sharing, regardless of the study or sponsor, with many more modules to come. And, of course, each sponsor organization can create its own secure information-sharing space that is only accessible to site users working on its trials, which may include embedded links that offer seamless access to sponsor-specific IT systems, such as clinical data management and site payments.
If you are an investigator, that likely sounds like a dream. One set of login credentials, one URL, and one standardized platform that offers everything you need. But, if you are a sponsor, you are probably already seeing some of the challenges that come along with this apparent utopia.
We’ll take a closer look at those challenges in the next post in this series. In the meantime, check out this brief video that describes a project we completed for one of the TransCelerate member companies, and fill out the form below to download our related guide, Perspectives on the TransCelerate Shared Investigator Platform.